APNA 11th Annual Clinical Psychopharmacology Institute Faculty


Carolyn Buppert, NP, JD – Health Care Attorney, Law Office of Carolyn Buppert, P.C.


Josh Hamilton, DNP, RN-BC, FNP-C, PMHNP-BC, CNE – Associate Dean, College of Nursing, West Coast University


Keynote: Thomas R. Insel, MD – Director, National Institute of Mental Health (NIMH), National Institutes of Health


Ellen Leibenluft, MD – Chief, Section on Bipolar Spectrum Disorders, Emotion and Development Branch, Mood and Anxiety Disorders Program, National Institute of Mental Health (NIMH), National Institutes of Health


Barbara J. Limandri, DNSc, APRN, BC – Professor, Linfield College of Nursing; PMHNP, Portland Dialectical Behavior Therapy Program


Geoffry Phillips McEnany, PhD, PMHCNS, BC – Professor, Department of Nursing, School of Health & Environment, Coordinator of Sleep & Sleep Disorders in Health and Disease Certificate Program, University of Massachusetts Lowell


Keynote: David K. Mineta – Deputy Director of Demand Reduction, Office of National Drug Control Policy


Mary D. Moller, DNP, ARNP, APRN, PMHCNS-BC, CPRP, FAAN – Associate Professor and Specialty Director for Psychiatric Mental Health Nursing, Yale University School of Nursing


Geraldine S. Pearson, PhD, PMH-CNS, APRN, FAAN – Associate Professor, Department of Psychiatry, University of Connecticut School of Medicine


Michael J. Rice PhD, APRN-NP, FAAN – Professor, College of Nursing, University of Nebraska Medical Center


Philip Shaw, MD, PhD – Earl Stadtman Investigator, Section on Neurobehavioral Clinical Research, Social and Behavioral Research Branch, National Human Genome Research Institute, and Adjunct Faculty, National Institute of Mental Health (NIMH)


Barbara Jones Warren, PhD, PMHCNS-BC, FAAN – Professor, Clinical Nursing, The Ohio State University


Peter J. Weiden, MD – Director, Psychosis Treatment Program, Department of Psychiatry, University of Illinois at Chicago